🇪🇺 Lexiva in European Union

Lexiva (FOSAMPRENAVIR) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/000534
  • Local brand name: Telzir
  • Status: withdrawn

Lexiva in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Lexiva approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Lexiva in European Union?

GSK is the originator. The local marketing authorisation holder may differ — check the official source linked above.